TCM
KZR

Tang Capital Management’s Kezar Life Sciences KZR Stock Holding History

Tang Capital Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93M Hold
664,314
– – 0.25% 38
2025
Q4 		$4.18M Sell
664,314
-55,686
-8% -$325K 0.21% 60
2025
Q3 		$2.81M Hold
720,000
– – 0.11% 113
2025
Q2 		$3.3M Hold
720,000
– – 0.17% 105
2025
Q1 		$3.51M Hold
720,000
– – 0.19% 93
2024
Q4 		$4.84M Buy
720,000
+355,970
+98% +$2.65M 0.32% 72
2024
Q3 		$2.81M Buy
+364,030
New +$2.2M 0.2% 90
2024
Q2 		– Sell
-68,894
Closed -$621K – 133
2024
Q1 		$621K Buy
68,894
+38,227
+125% +$348K 0.06% 93
2023
Q4 		$291K Buy
+30,667
New +$270K 0.03% 119

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Tang Capital Management's KZR Position: Q1 2026 in Review

Tang Capital Management held its Kezar Life Sciences (KZR) position steady in Q1 2026 at 664,314 shares worth $4.93M. The position accounts for 0.25% of the portfolio, ranked #38.

Tang Capital Management first reported a position in KZR in Q4 2023 and has held it in 9 quarters since. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Tang Capital Management held 664,314 shares of Kezar Life Sciences worth $4.93M as of Q1 2026.
  • Tang Capital Management left its Kezar Life Sciences share count unchanged in Q1 2026.
  • Kezar Life Sciences made up 0.25% of Tang Capital Management's portfolio in Q1 2026, its #38 holding.
  • Tang Capital Management first reported a position in Kezar Life Sciences in Q4 2023 and has held it in 9 quarters since.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.